CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $70.60 billion. The enterprise value is $138.34 billion.
| Market Cap | 70.60B |
| Enterprise Value | 138.34B |
Important Dates
The next confirmed earnings date is Wednesday, November 6, 2024, before market open.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | Oct 21, 2024 |
Share Statistics
CVS Health has 1.26 billion shares outstanding. The number of shares has decreased by -2.15% in one year.
| Shares Outstanding | 1.26B |
| Shares Change (YoY) | -2.15% |
| Shares Change (QoQ) | -0.63% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 82.88% |
| Float | 1.26B |
Valuation Ratios
The trailing PE ratio is 9.97 and the forward PE ratio is 8.46. CVS Health's PEG ratio is 2.27.
| PE Ratio | 9.97 |
| Forward PE | 8.46 |
| PS Ratio | 0.20 |
| Forward PS | 0.18 |
| PB Ratio | 0.94 |
| P/FCF Ratio | 13.39 |
| PEG Ratio | 2.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.59, with an EV/FCF ratio of 26.24.
| EV / Earnings | 19.24 |
| EV / Sales | 0.38 |
| EV / EBITDA | 8.59 |
| EV / EBIT | 11.98 |
| EV / FCF | 26.24 |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of 1.12.
| Current Ratio | 0.86 |
| Quick Ratio | 0.60 |
| Debt / Equity | 1.12 |
| Debt / EBITDA | 4.36 |
| Debt / FCF | 15.90 |
| Interest Coverage | 4.08 |
Financial Efficiency
Return on equity (ROE) is 9.73% and return on invested capital (ROIC) is 4.60%.
| Return on Equity (ROE) | 9.73% |
| Return on Assets (ROA) | 2.87% |
| Return on Capital (ROIC) | 4.60% |
| Revenue Per Employee | $1.21M |
| Profits Per Employee | $23,967 |
| Employee Count | 300,000 |
| Asset Turnover | 1.44 |
| Inventory Turnover | 18.58 |
Taxes
In the past 12 months, CVS Health has paid $2.44 billion in taxes.
| Income Tax | 2.44B |
| Effective Tax Rate | 25.28% |
Stock Price Statistics
The stock price has decreased by -18.65% in the last 52 weeks. The beta is 0.53, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | -18.65% |
| 50-Day Moving Average | 59.86 |
| 200-Day Moving Average | 64.90 |
| Relative Strength Index (RSI) | 31.66 |
| Average Volume (20 Days) | 14,514,304 |
Short Selling Information
The latest short interest is 19.75 million, so 1.57% of the outstanding shares have been sold short.
| Short Interest | 19.75M |
| Short Previous Month | 18.50M |
| Short % of Shares Out | 1.57% |
| Short % of Float | 1.57% |
| Short Ratio (days to cover) | 2.27 |
Income Statement
In the last 12 months, CVS Health had revenue of $361.86 billion and earned $7.19 billion in profits. Earnings per share was $5.63.
| Revenue | 361.86B |
| Gross Profit | 52.00B |
| Operating Income | 11.55B |
| Pretax Income | 9.63B |
| Net Income | 7.19B |
| EBITDA | 16.10B |
| EBIT | 11.55B |
| Earnings Per Share (EPS) | $5.63 |
Balance Sheet
The company has $16.26 billion in cash and $83.82 billion in debt, giving a net cash position of -$67.56 billion or -$53.71 per share.
| Cash & Cash Equivalents | 16.26B |
| Total Debt | 83.82B |
| Net Cash | -67.56B |
| Net Cash Per Share | -$53.71 |
| Equity (Book Value) | 75.11B |
| Book Value Per Share | 59.66 |
| Working Capital | -11.43B |
Cash Flow
In the last 12 months, operating cash flow was $8.07 billion and capital expenditures -$2.80 billion, giving a free cash flow of $5.27 billion.
| Operating Cash Flow | 8.07B |
| Capital Expenditures | -2.80B |
| Free Cash Flow | 5.27B |
| FCF Per Share | $4.19 |
Margins
Gross margin is 14.37%, with operating and profit margins of 3.19% and 1.99%.
| Gross Margin | 14.37% |
| Operating Margin | 3.19% |
| Pretax Margin | 2.66% |
| Profit Margin | 1.99% |
| EBITDA Margin | 4.45% |
| EBIT Margin | 3.19% |
| FCF Margin | 1.45% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 4.74%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 4.74% |
| Dividend Growth (YoY) | 9.92% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 47.23% |
| Buyback Yield | 2.15% |
| Shareholder Yield | 6.89% |
| Earnings Yield | 10.18% |
| FCF Yield | 7.47% |
Analyst Forecast
The average price target for CVS Health is $75.39, which is 34.34% higher than the current price. The consensus rating is "Buy".
| Price Target | $75.39 |
| Price Target Difference | 34.34% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 5.06% |
| EPS Growth Forecast (5Y) | 10.38% |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.18 |
| Piotroski F-Score | 6 |